Effects of a Manual Therapy Program to Reduce the Evolution Time of Axillary Web Syndrome
Launched by UNIVERSITY OF MALAGA · Oct 30, 2021
Trial Information
Current as of November 13, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a manual therapy program designed to help patients who have developed Axillary Web Syndrome (AWS) after breast cancer surgery, specifically mastectomy. AWS can cause discomfort and limit movement in the arm, which may delay important cancer treatments like radiotherapy. The goal of the study is to see if specific exercises and stretching, led by a trained physiotherapist, can reduce the time AWS lasts, helping patients regain mobility and alleviate pain more quickly.
To be eligible for this trial, participants must be at least 18 years old, have undergone a mastectomy, and have a lymphatic thrombus (a blockage in the lymphatic system) in the arm on the same side as their surgery. The trial is open to all genders. Participants can expect to receive guided therapy to help with their symptoms, and their progress will be compared to a control group who will not receive the same treatment. This study could provide valuable insights into improving recovery for those affected by AWS.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient over 18 years old.
- • Mastectomized patients (either radical or conservative surgery).
- • Patient with lymphatic thrombus in the upper limb ipsilateral to the surgical intervention.
- Exclusion Criteria:
- • Significant psychological alterations that would prevent the retrieval of the information necessary for the investigation.
- • Significant neurological alterations that would prevent the retrieval of the information necessary for the investigation.
- • Patients in a situation of legal dispute that would affect their intervention in this study.
- • Metastasis not treated with chemotherapy treatment.
About University Of Malaga
The University of Malaga, a leading academic institution in Spain, is committed to advancing medical research and improving patient outcomes through innovative clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive resources and expertise in various fields, including medicine, health sciences, and biotechnology, to conduct rigorous studies. The institution is dedicated to fostering a culture of ethical research practices and ensuring the highest standards of safety and efficacy in its clinical trials, ultimately contributing to the development of groundbreaking therapies and enhancing the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Algeciras, Cádiz, Spain
Algeciras, Spain
Patients applied
Trial Officials
Rocío Martín Valero, Physiothera
Study Director
Malaga U
María Jesús Viñolo Gil, Physiothera
Study Director
Cádiz U
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials